Parkman Healthcare Partners LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001777015

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q2 2025 · 88 positions · Total reported value $870.09M · Top-10 concentration 32.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 68.0% · 26 new · 31 cut · 13 exited

Active Share (vs S&P 500): 97.4% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.8% · vs SPY -4.9% · Prev Value $976.83M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.8% · vs SPY -4.0% · Latest Value $1.11B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2025 13F filing, Parkman Healthcare Partners LLC disclosed 88 equity positions with a combined reported value of $870.09M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 32.2% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2025 were CVS ($35.72M), PODD ($33.23M), BSX ($30.41M). By sector, the heaviest allocations are Health Care 78.9%, Industrials 5.1%. Versus the prior quarter, allocation shifted toward Industrials (+1.6pp), Technology (+1.5pp) and away from Health Care (-4.6pp).

Versus the prior quarter, Parkman Healthcare Partners LLC opened 26 new positions, trimmed 31 and fully exited 13, a turnover rate of 68.0% of positions. The portfolio's overlap with the prior quarter was 74% of names.

The largest new positions opened in Q2 2025 were IQV ($17.26M), WGS ($16.15M), ASND ($7.27M).

Of the 13 positions fully exited versus the prior quarter, the largest were BDX ($27.55M), UNH ($26.30M), RMD ($5.06M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2025)

  • IQV IQVIA HLDGS INC · $17.26M
  • WGS GENEDX HOLDINGS CORP · $16.15M
  • ASND ASCENDIS PHARMA A/S · $7.27M
  • CERT CERTARA INC · $5.85M
  • ALKS ALKERMES PLC · $5.72M
  • WAY WAYSTAR HLDG CORP · $5.72M
  • INCY INCYTE CORP · $5.11M
  • AMLX AMYLYX PHARMACEUTICALS INC · $4.17M

Fully Exited (vs previous quarter)

  • BDX BECTON DICKINSON & CO · prev qtr: $27.55M
  • UNH UNITEDHEALTH GROUP INC · prev qtr: $26.30M · history
  • RMD RESMED INC · prev qtr: $5.06M
  • GH GUARDANT HEALTH INC · prev qtr: $3.81M
  • PCVX VAXCYTE INC · prev qtr: $3.53M
  • INSM INSMED INC · prev qtr: $2.89M · history
  • KROS KEROS THERAPEUTICS INC · prev qtr: $2.22M
  • NAMS NEWAMSTERDAM PHARMA COMPANY · prev qtr: $2.07M

Insider Transactions (Form 4)

Latest Parkman Healthcare Partners LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Parkman Healthcare Partners LLC, based in Stamford, CT, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 77 positions worth $976.83M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: STAMFORD, CT, United States
  • SEC registration: 801-114849 (status: Approved), registered 2019-03-15
  • Regulatory AUM (Form ADV): $1.74B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 77 positions · $976.83M reported value (Q2 2026)
  • Top 10 holdings = 33.5% of reported value
  • Largest position: MBX (MBX BIOSCIENCES INC COM) at 4.5%
  • Average position size: $12.69M

Sector Tilt

  • Health Care 92.1%
  • Consumer Staples 4.1%
  • Industrials 3.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 18 new, 25 added, 30 reduced, 31 exited
  • 4 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 78.9%
Technology 2.2%
Other 8.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 517.81K $35.72M 4.11%
4.11%
Add
2 105.76K $33.23M 3.82%
3.82%
Reduce
3 283.17K $30.41M 3.50%
3.50%
Add
4 92.34K $30.11M 3.46%
3.46%
Add
5 168.88K $29.72M 3.42%
3.42%
Reduce
6 385.48K $27.43M 3.15%
3.15%
Add
7 33.30K $25.96M 2.98%
2.98%
Reduce
8 498.11K $23.94M 2.75%
2.75%
Add
9 240.40K $21.93M 2.52%
2.52%
Add
10 110.09K $21.75M 2.50%
2.50%
Add
11 166.01K $20.87M 2.40%
2.40%
Reduce
12 50.38K $19.93M 2.29%
2.29%
Reduce
13 225.88K $19.72M 2.27%
2.27%
Add
14 251.74K $19.69M 2.26%
2.26%
Add
15 197.90K $18.72M 2.15%
2.15%
Reduce
16 1.30M $18.16M 2.09%
2.09%
Add
17 109.50K $17.26M 1.98%
1.98%
New
18 175.00K $16.15M 1.86%
1.86%
New
19 157.20K $15.20M 1.75%
1.75%
Add
20 131.68K $14.60M 1.68%
1.68%
Reduce
21 488.80K $13.52M 1.55%
1.55%
Reduce
22 17.46K $12.79M 1.47%
1.47%
Reduce
23 225.15K $12.38M 1.42%
1.42%
Reduce
24 827.06K $12.24M 1.41%
1.41%
Reduce
25 587.56K $11.82M 1.36%
1.36%
Add
26 174.28K $11.48M 1.32%
1.32%
Add
27 386.65K $11.14M 1.28%
1.28%
Add
28 549.05K $10.55M 1.21%
1.21%
Add
29 871.93K $9.95M 1.14%
1.14%
Add
30 2.11M $9.84M 1.13%
1.13%
Add
31 119.62K $9.13M 1.05%
1.05%
Add
32 1.01M $9.03M 1.04%
1.04%
Add
33 181.64K $8.87M 1.02%
1.02%
Reduce
34 162.98K $8.57M 0.98%
0.98%
Add
35 647.33K $8.49M 0.97%
0.97%
Add
36 128.48K $8.38M 0.96%
0.96%
Add
37 896.71K $8.33M 0.96%
0.96%
Reduce
38 633.87K $8.24M 0.95%
0.95%
Hold
39 867.81K $8.13M 0.93%
0.93%
Add
40 175.00K $7.88M 0.91%
0.91%
Add
41 715.50K $7.86M 0.90%
0.90%
Add
42 679.06K $7.68M 0.88%
0.88%
Reduce
43 120.83K $7.41M 0.85%
0.85%
Add
44 41.00K $7.36M 0.85%
0.85%
Reduce
45 674.55K $7.32M 0.84%
0.84%
Add
46 42.11K $7.27M 0.83%
0.83%
New
47 648.87K $7.20M 0.83%
0.83%
Add
48 352.26K $7.19M 0.83%
0.83%
Hold
49 1.90M $7.11M 0.82%
0.82%
Reduce
50 507.42K $6.85M 0.79%
0.79%
Add

FAQ

What did Parkman Healthcare Partners LLC buy in 2025-Q2?

In its 2025-Q2 13F filing, Parkman Healthcare Partners LLC reported 88 equity positions worth $870.09M in aggregate; its largest disclosed positions were CVS ($35.72M), PODD ($33.23M), BSX ($30.41M).

How large is Parkman Healthcare Partners LLC's portfolio?

Parkman Healthcare Partners LLC reported $870.09M of long equity holdings across 88 positions as of 2025-Q2. Top-10 holdings account for 32.2% of reported value.

What is Parkman Healthcare Partners LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/parkman-healthcare-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →